Abiopharma

🔍 CHANG NANCY T (Director)

Company: Immix Biopharma, Inc. (IMMX)

Report Date: 2025-11-21

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2025-11-21 | Code: H | shares_owned_after: 421,940.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-11-21 | Code: H | nature_of_ownership: Held by Robinhood II, LP | shares_owned_after: 496,940.00 | Footnotes: F1
• Acquired 39,643 shares of Stock Option (Right to Buy) at $4.33 per share (Derivative)
  Date: 2025-11-21 | Code: A | Expires: 2035-11-21 | equity_swap_involved: 0 | shares_owned_after: 39,643.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Dr. Nancy T. Chang is the general manager of Robinhood II, LP and may be deemed to beneficially own the securities held by Robinhood II, LP. Dr. Chang disclaims beneficial ownership of the common stock owned directly by Robinhood II, LP, except to the extent of her pecuniary interest therein.
• F2: The Stock Option will vest in thirty-six (36) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer and the terms of a Stock Option Agreement entered into to evidence the award.